/ Print /

LATEST

Prevent polypharmacy problemsPolypharmacy presents real problems—especially for older adults.
Top four patient engagement trends to watchThese trends emerge from CDW’s Patient Engagement Perspective Study, but surprisingly one tech trend didn’t make the cut.
Four reasons GOP ACA replacement failed without a voteWhat exactly did House representatives on both sides of the aisle dislike about the AHCA? Here’s a look at what MCOs should know.
Three ways smarter technology is improving diabetes careCould new technology solve America’s diabetes crisis? Find out.
New C-suite position to watch: Chief experience officers
New C-suite position to watch: Chief experience officersChief experience officers improve the patient experience—and the experience of caregivers.
New therapies show promise in treating diabetes
New therapies show promise in treating diabetesNew updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes.
Bariatric surgery costs vs. benefits: Plan coverage considerationsFrom a healthcare perspective, bariatric surgery is considered one of the most effective options for short-term and sustained weight loss. But does the investment pay off?
Shifting trends in the pharmaceutical marketplace: What to watchFrom public furor over price hikes to the loss of patent protections for blockbuster drugs, big changes are afoot in the pharmaceutical marketplace. Read more.
Incremental clinical advances for Duchenne Muscular DystrophyJust last year, the FDA approved Exondys 51 (eteplirsen) for DMD, over the recommendations of FDA scientists and an external scientific advisory committee. Read more.
Rapid oncology innovation raises management challenges for payersOncology is a complex and rapidly-evolving management challenge for payers.